Galaxy Digital: GENIUS stablecoin could bring up to $1.
According to ChainCatcher, Galaxy Research Head of Research Alex Thorn published a post revealing that Galaxy Research has released its latest report, which refutes the banking industry’s claim that the “GENIUS Act” will impact US bank deposits and provides quantitative analysis results.
The key findings of the report are as follows: under the GENIUS Act framework, 60% to 70% of stablecoin inflows will originate from overseas, with inflows from foreign deposits approximately double the amount of domestic deposit migration, meaning that overall it is a net increase rather than a shift of existing funds; for each newly minted GENIUS stablecoin, about $0.32 of net credit is generated for the US economy; by 2030, the base scenario projects total credit expansion of about $40 billion, rising to $120 billion in the optimistic scenario. In addition, US Treasury bill yields are expected to compress by 3 to 5 basis points, potentially saving taxpayers up to $3 billion in annual borrowing costs. The report also notes that the interest transfer mechanism does not pose an existential threat to the US banking sector, but is merely a redistribution of profit margins and will not diminish overall credit capacity.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go
Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.
RBA Minutes: Case for rates to act promptly to keep inflation expectations anchored
